Raghuveer Ranganathan

Targeting protein–ligand neosurfaces with a generalizable deep learning tool

Naturally occurring T cell mutations enhance engineered T cell therapies

A Chimeric Switch-Receptor Targeting PD1 Augments the Efficacy of Second-Generation CAR T Cells in Advanced Solid Tumors

Multifactorial T-cell Hypofunction That Is Reversible Can Limit the Efficacy of Chimeric Antigen Receptor–Transduced Human T cells in Solid Tumors